Home » Newsletters » BioWorld Science

BioWorld Science

March 18, 2021

View Archived Issues

Anelixis begins phase II study of immunomodulation with AT-1501 in islet cell transplant

Selexis and Pandion to advance development of PT-627

Ventyx initiates dosing in phase I study of VTX-958 for autoimmune diseases

CohBar selects CB5138-3 as lead candidate for IPF and other fibrotic diseases

FDA clears initiation of phase I study of Meissa's COVID-19 vaccine candidate MV-014-212

Therapeutics Solutions plans to use StemVacs to treat COVID-19

T-Cure enters clinical research agreement to support phase I study of KK-LC-1 TCR therapy

Updated interim data reported from phase I/II study of GTB-3550 TriKE

Induced blastocysts are model for earliest development stages

AbbVie presents first-in-human data for ABBV-3373

Immatics reports data updates from ongoing phase I studies of its ACTengine candidates

New results presented for oral formulation of milvexian

Phase III data for omidubicel versus standard UCB in high-risk hematologic malignancies

Chinese phase I study begins with LPM-3480392

Ide-cel induces responses in heavily pretreated patients with refractory/relapsed myeloma

Lipopolysaccharides induce neural repair sweet spot

Data flaws sink current AI models for COVID-19 diagnosis

High blood fats, sugars alter antigen processing

Translate Bio reports second interim analysis of phase I/II trial of MRT-5005 for cystic fibrosis

Phase III topline data reported from ARISE-3 trial of RGN-259 in dry eye

PDE4 inhibitors divulged by Hubei Bio-Pharmaceutical, Humanwell Healthcare

Hefei Institutes of Physical Sciences presents new PDGFR-alpha and/or PDGFR-beta inhibitors

New hydroxyacid oxidase 1 inhibitors discovered at OxaluRx

HBV caspid assembly inhibitors patented by Tibet Tiansheng Taifeng Pharmaceutical

Gilead describes compounds for Filoviridae virus infections

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 10, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026